Interim FDG-PET in lymphoma, a questionable practice in hematology.

about

Interim FDG-PET in lymphoma, a questionable practice in hematology.

Item

http://www.wikidata.org/entity/Q48316502

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Interim FDG-PET in lymphoma, a questionable practice in hematology.

@en

Interim FDG-PET in lymphoma, a questionable practice in hematology.

@nl

type

Item

label

Interim FDG-PET in lymphoma, a questionable practice in hematology.

@en

Interim FDG-PET in lymphoma, a questionable practice in hematology.

@nl

prefLabel

Interim FDG-PET in lymphoma, a questionable practice in hematology.

@en

Interim FDG-PET in lymphoma, a questionable practice in hematology.

@nl

P1476

Interim FDG-PET in lymphoma, a questionable practice in hematology

@en

P2093

Thomas C Kwee

http://www.w3.org/2001/XMLSchema#string

P2860

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Hodgkin's lymphoma: the pathologist's viewpoint

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.

Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy.

Report of the 6th International Workshop on PET in lymphoma.

P2888

s00259-017-3783-4

P304

2014-2017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S00259-017-3783-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hugo J A Adams

P577

2017-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28761975

http://www.w3.org/2001/XMLSchema#string